Oxidative stress and inflammation in obesity, diabetes, hypertension, and related cardiometabolic complications

Oxidative Medicine and Cellular Longevity

Volumn 2014, Issue , 2014, Pages

  Ndisang, Joseph Fomusi ^a   Vannacci, Alfredo ^b   Rastogi, Sharad ^c  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF FLORENCE   (Italy)

^c HENRY FORD HEART AND VASCULAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; 4 HYDROXYNONENAL; ADIPONECTIN; APOLIPOPROTEIN; ATRIAL NATRIURETIC FACTOR; CARBON MONOXIDE; COPPER; GLYCOGEN SYNTHASE KINASE 3; HEME OXYGENASE; HEXOKINASE; HEXOKINASE ISOENZYME; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN; ZINC; TRACE ELEMENT;

APOPTOSIS; ATHEROSCLEROTIC PLAQUE; CARDIOMETABOLIC COMPLICATION; CAROTID ENDARTERECTOMY; CELL FUNCTION; COLITIS; DIABETES MELLITUS; EDITORIAL; EXTRACELLULAR MATRIX; GLYCOGEN METABOLISM; HEART FAILURE; HEART FUNCTION; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; INSULIN RESISTANCE; KIDNEY FUNCTION; LIPID DIET; LIPID STORAGE; LIPOPROTEIN BLOOD LEVEL; MAGNOLIA OFFICINALIS; MAGNOLIACEAE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEDICINAL PLANT; MULTIFACTORIAL GENETIC DISORDER; NONHUMAN; OBESITY; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEINURIA; TWO DIMENSIONAL ELECTROPHORESIS; ANIMAL; COMPLICATION; METABOLISM; PATHOLOGY;

ANIMALS; APOLIPOPROTEINS; DIABETES COMPLICATIONS; HEME OXYGENASE (DECYCLIZING); HUMANS; HYPERTENSION; INFLAMMATION; OBESITY; OXIDATIVE STRESS; TRACE ELEMENTS;

EID: 84897000178     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2014/506948     Document Type: Editorial

References (22)

1. Jadhav A., Ndisang J. F., Heme arginate suppresses cardiac lesions and hypertrophy in deoxycorticosterone acetate-salt hypertension. Experimental Biology and Medicine 2009 234 7 764 778 2-s2.0-67650260800 10.3181/0810-RM-302
2. Ndisang J. F., Jadhav A., Upregulating the heme oxygenase system suppresses left ventricular hypertrophy in adult spontaneously hypertensive rats for 3 months. Journal of Cardiac Failure 2009 15 7 616 628 2-s2.0-68849093674 10.1016/j.cardfail.2009.02.003
3. Ndisang J. F., Jadhav A., Fomusi Ndisang J., The heme oxygenase system attenuates pancreatic lesions and improves insulin sensitivity and glucose metabolism in deoxycorticosterone acetate hypertension. The American Journal of Physiology-Regulatory Integrative and Comparative Physiology 2010 298 1 R211 R223 2-s2.0-73549113296 10.1152/ajpregu.91000.2008
4. Malik V. S., Willett W. C., Hu F. B., Global obesity: trends, risk factors and policy implications. Nature Reviews Endocrinology 2013 9 13 27
5. Han J. C., Lawlor D. A., Kimm S. Y., Childhood obesity. The Lancet 2010 375 9727 1737 1748 2-s2.0-77952323536 10.1016/S0140-6736(10)60171-7
6. Hirata Y., Tabata M., Kurobe H., Motoki T., Akaike M., Nishio C., Higashida M., Mikasa H., Nakaya Y., Takanashi S., Igarashi T., Kitagawa T., Sata M., Coronary atherosclerosis is associated with macrophage polarization in epicardial adipose tissue. Journal of the American College of Cardiology 2011 58 3 248 255 2-s2.0-79960065980 10.1016/j.jacc.2011.01.048
7. Navarro-González J. F., Mora-Fernández C., De Fuentes M. M., García-Pérez J., Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nature Reviews Nephrology 2011 7 6 327 340 2-s2.0-79957874666 10.1038/nrneph.2011.51
8. Navarro-Gonzalez J. F., Mora-Fernandez C., Inflammatory pathways. Contributions to Nephrology 2011 170 113 123 10.1159/000325646
9. Lutgens E., Van Suylen R.-J., Faber B. C., Gijbels M. J., Eurlings P. M., Bijnens A.-P., Cleutjens K. B., Heeneman S., Daemen M. J. A. P., Atherosclerotic plaque rupture: local or systemic process? Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 12 2123 2130 2-s2.0-0346753453 10.1161/01.ATV.0000097783.01596.E2 (Pubitemid 37532310)
10. Libby P., Inflammation in atherosclerosis. Nature 2002 420 6917 868 874 2-s2.0-0037180771 10.1038/nature01323 (Pubitemid 36019640)
11. Skålén K., Gustafsson M., Knutsen Rydberg E., Hultén L. M., Wiklund O., Innerarity T. L., Boren J., Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature 2002 417 6890 750 754 2-s2.0-0037071843 10.1038/nature00804 (Pubitemid 34640629)
12. Jadhav A., Torlakovic E., Ndisang J. F., Hemin therapy attenuates kidney injury in deoxycorticosterone acetate-salt hypertensive rats. The American Journal of Physiology-Renal Physiology 2009 296 3 F521 F534 2-s2.0-66049154851 10.1152/ajprenal.00510.2007
13. Ndisang J. F., Lane N., Jadhav A., Upregulation of the heme oxygenase system ameliorates postprandial and fasting hyperglycemia in type 2 diabetes. The American Journal of Physiology-Endocrinology and Metabolism 2009 296 5 E1029 E1041 2-s2.0-66149135526 10.1152/ajpendo.90241.2008
14. Ndisang J. F., Jadhav A., Hemin therapy improves kidney function in male streptozotocin-induced diabetic rats: role of the heme oxygenase/atrial natriuretic peptide/adiponectin axis. Endocrinology 2014 155 215 229 10.1210/en.2013-1050
15. Ndisang J. F., Jadhav A., Hemin therapy suppresses inflammation and retroperitoneal adipocyte hypertrophy to improve glucose metabolism in obese rats co-morbid with insulin-resistant type-2 diabetes. Diabetes, Obesity and Metabolism 2013 15 1029 1039 10.1111/dom.12130
16. Tang X., Zheng D., Hu P., Zeng Z., Li M., Tucker L., Monahan R., Resnick M. B., Liu M., Ramratnam B., Glycogen synthase kinase 3 beta inhibits microRNA-183-96-182 cluster via the beta-Catenin/TCF/LEF-1 pathway in gastric cancer cells. Nucleic Acids Research 2013 10.1093/nar/gkt1275
17. Ali A., Hoeflich K. P., Woodgett J. R., Glycogen synthase kinase-3: properties, functions, and regulation. Chemical Reviews 2001 101 8 2527 2540 2-s2.0-0035413614 10.1021/cr000110o (Pubitemid 35373033)
18. Poulsen H. E., Specht E., Broedbaek K., Henriksen T., Ellervik C., Mandrup-Poulsen T., Tonnesen M., Nielsen P. E., Andersen H. U., Weimann A., RNA modifications by oxidation: a novel disease mechanism? Free Radical Biology and Medicine 2012 52 8 1353 1361 2-s2.0-84858998993 10.1016/j.freeradbiomed.2012.01. 009
19. Cooper G. J., Selective divalent copper chelation for the treatment of diabetes mellitus. Current Medicinal Chemistry 2012 19 2828 2860 10.2174/092986712800609715
20. Li B., Tan Y., Sun W., Fu Y., Miao L., Cai L., The role of zinc in the prevention of diabetic cardiomyopathy and nephropathy. Toxicology Mechanisms and Methods 2013 23 27 33 10.3109/15376516.2012.735277
21. Sun L., Yu Y., Huang T., An P., Yu D., Yu Z., Li H., Sheng H., Cai L., Xue J., Jing M., Li Y., Lin X., Wang F., Associations between ionomic profile and metabolic abnormalities in human population. PLoS ONE 2012 7 e38845
22. Zheng Y., Li X.-K., Wang Y., Cai L., The role of zinc, copper and iron in the pathogenesis of diabetes and diabetic complications: therapeutic effects by chelators. Hemoglobin 2008 32 1-2 135 145 2-s2.0-39349103963 10.1080/03630260701727077 (Pubitemid 351264519)